Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Two major Wall Street firms opened coverage of Aevex Corp this week with optimistic ratings, pointing to the drone maker's combat-proven product set and manufacturing scale as advantages as defense spending on autonomous systems increases. Analysts from Jefferies and Raymond James issued Buy-equivalent recommendations with price targets of $32 and …
Mereo BioPharma disclosed its first quarter 2026 financial results and corporate updates, emphasizing ongoing regulatory discussions regarding setrusumab's potential pediatric use, active partnership talks for alvelestat Phase 3 development, and advancement of vantictumab's Phase 2 trial. Despite not meeting primary endpoints in setrusumab Phase 3 …
TappAlpha has announced surpassing $500 million in assets under management, doubling within just four months. The company's Growth + Income ETF strategies, including TSPY and TDAQ, focus on combining growth exposure with a tax-efficient income overlay. This milestone reflects strong advisor and investor demand for strategies that generate income wi…
Xilio Therapeutics reported strong first-quarter 2026 financial and operational results. The company is on track to submit an IND for XTX501, a bispecific PD-1/masked IL-2 therapy, mid-2026, with Phase 1 trial initiation planned for the second half of 2026. It presented promising preclinical data for XTX601 targeting CLDN18.2 and advanced multi-spe…
BriaCell Therapeutics Corp. reports that over 230 patients have been enrolled in its pivotal Phase 3 Bria-ABC study testing Bria-IMT in combination with an immune checkpoint inhibitor for metastatic breast cancer. The study, which has FDA Fast Track designation, expects to report interim topline overall survival data in 2026, potentially supporting…
Harvard Bioscience announced its financial results for Q1 2026, achieving revenues of $20.8 million with a gross margin improvement to 59%. The company remains profitable on an adjusted EBITDA basis and is progressing on manufacturing consolidation to achieve cost efficiencies. Adoption of higher-margin new product innovations (NPI), such as the Me…
Aveanna Healthcare Holdings Inc. announced its participation and presentation at the William Blair 46th Annual Growth Stock Conference on June 2, 2026. The company will showcase its range of pediatric and adult healthcare services, highlighting its focus on providing high-quality, cost-effective care alternatives to prolonged hospitalization.
Compass Therapeutics, a clinical-stage oncology-focused biopharmaceutical company, announced its participation in two major investor events in May 2026: the H.C. Wainwright 4th Annual BioConnect Investor Conference and the 2026 Stifel Virtual Targeted Oncology Forum. The company will provide webcast presentations and offer one-on-one meetings for i…
SAB Biotherapeutics announced Q1 2026 financial results and highlighted ongoing enrollment in their registrational Phase 2b SAFEGUARD trial of SAB-142 for type 1 diabetes. The company reported encouraging Phase 1 data showing C-peptide preservation and better glycemic control, secured $95 million from a public offering to fund operations through 20…
Sagimet Biosciences reported strong first quarter 2026 financial results, highlighted by securing $175 million in equity financing to fund operations through 2028. The company announced plans to initiate a Phase 3 clinical trial of its novel acne drug denifanstat in the U.S. in the second half of 2026, targeting moderate to severe acne. Ongoing Pha…
BridgeBio Pharma has submitted a New Drug Application (NDA) to the FDA for encaleret, a targeted treatment for autosomal dominant hypocalcemia type 1 (ADH1). The Phase 3 CALIBRATE trial met all primary and key secondary endpoints, demonstrating rapid and durable improvements in calcium regulation and a favorable safety profile. Encaleret may receiv…
Zevra Therapeutics, a commercial-stage biopharmaceutical company focused on rare diseases, announced its executive team will present at the H.C. Wainwright BioConnect Investor Conference to discuss the company's progress and strategic outlook. The presentation underscores Zevra's commitment to advancing its pipeline and broadening patient access to…
Nayax Ltd. announced robust financial results for Q1 2026, reporting a 32% increase in revenue to $106.9 million, organic revenue growth of 26%, and a 43% year-over-year increase in adjusted EBITDA to $13.9 million. The company expanded its installed base to over 1.5 million devices and customer base to 120,000, demonstrating successful scale and r…
The Kremlin has reiterated Russian President Vladimir Putin’s recent comment that the conflict in Ukraine is drawing to a close, citing groundwork toward a peace process. Kyiv, however, including President Volodymyr Zelenskiy, has expressed scepticism about Moscow’s intentions, and fighting continued despite a short U.S.-mediated ceasefire.
Wendy's Corp. saw its stock jump in premarket trading after a report said Trian Fund Management, headed by Nelson Peltz, has been seeking outside investor support for a possible bid to take the company private. Discussions reportedly included contacts in the Middle East. The firm has not made a formal offer and both Wendy's and Trian declined to pr…
TransUnion's latest report reveals that the median age of renters has risen to 40, with many delaying or foregoing homeownership due to economic factors. This demographic shift presents a strategic growth opportunity for insurers, as these renters demonstrate stable incomes, strong credit profiles, and increasing demand for comprehensive insurance …
POET Technologies Inc., a Nasdaq-listed company specializing in integrated optical engines and light sources for AI networks, announced the appointment of Sandeep Kumar as Chief Operating Officer. Dr. Kumar brings extensive semiconductor operations experience from Silicon Labs and other industry leaders. His immediate focus will be on preparing POE…
Hub Group, Inc. has filed a Notification of Late Filing for its quarterly report and disclosed delays in its annual report due to identified accounting inaccuracies requiring restatement of financials for 2023, 2024, and part of 2025. Despite operational growth in intermodal and logistics, brokerage volume declined as the company focuses on profita…
Australia's Treasury has modelled a severe scenario in its budget papers in which an escalation of the conflict in Iran disrupts regional energy and export infrastructure, lifting oil to $200 per barrel in the July-September window and triggering a quarterly contraction, a sharp rise in inflation and higher unemployment.
Qualcomm remains uniquely positioned where mobile connectivity, edge AI, and automotive telematics converge. This trade idea lays out a mid-term long with a clear entry, target and stop, aiming to capture incremental revenue growth from chipset ramps and licensing leverage while respecting execution and policy risks.
Barclays Research rates European Value shares Positive after they led factor performance on earnings days in Q1 2026, supported by a pickup in blended EPS growth and improving earnings momentum. Momentum positioning looks stretched, while Value's sector tilt toward Financials and Cyclicals and a lower forward P/E versus history underpin the bank's …
Government data released on Tuesday showed India’s year-on-year consumer price inflation rose to 3.48% in April, lifted by firmer food prices. Economists warn that elevated crude prices linked to the Middle East conflict, a weaker rupee, fertiliser cost pressures and the prospect of a below-normal monsoon raise the risk of higher inflation ahead, t…
Under Armour said it expects fiscal 2027 revenue to decline slightly and projected adjusted earnings per share well below analyst forecasts, as soft consumer spending and broader economic uncertainty damp demand in its core North American market. The announcement sent the stock down 12% in premarket trading and renewed questions about the company’s…
Bank of America card transaction data indicate total household spending increased 4.8% year-over-year in April and rose 0.6% month-over-month on a seasonally adjusted basis. Growth across spending categories was mixed: higher gas spending driven by prices contrasted with continued strength in online retail, while department stores, home improvement…
OpenAI is granting select European companies access to its newest models, including GPT-5.5-Cyber, through a program aimed at equipping trusted defenders with tools for identifying and responding to vulnerabilities. The initiative covers firms across finance, telecommunications, energy and public services, and coincides with broader company moves t…
